Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Imiquimod in clinical practice

L Edwards1

  • 1Carolinas Medical Center, Charlotte, North Carolina, USA.

The Australasian Journal of Dermatology
|December 8, 1998
PubMed
Summary
This summary is machine-generated.

Topical 5% imiquimod cream effectively treats genital warts by inducing interferon-alpha. Applied overnight three times weekly, it cleared warts in 50% of patients with a low recurrence rate.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anaesthetic management of abdominal trauma.

BJA education·2025
Same author

Factors that influence the quality of the clinical supervision experience in a first contact physiotherapy (FCP) role - The perspectives of supervisors and supervisees - A qualitative analysis.

Musculoskeletal science & practice·2024
Same author

Management of acute cervical spinal cord injury in the non-specialist intensive care unit: a narrative review of current evidence.

Anaesthesia·2023
Same author

Bi-national outbreak of <i>Salmonella</i> Newport infections linked to onions: the United States experience.

Epidemiology and infection·2022
Same author

Point-of-care lung ultrasound in the assessment of suspected COVID-19: a retrospective service evaluation with a severity score.

Acute medicine·2020
Same author

The design and manufacture of 3D-printed adjuncts for powered air-purifying respirators.

Anaesthesia reports·2020
Same journal

Benzalkonium Chloride in Eye Drops Causing Allergic Contact Dermatitis: A Case Series.

The Australasian journal of dermatology·2026
Same journal

The Dermatologist's Role in Early PMOS Diagnosis.

The Australasian journal of dermatology·2026
Same journal

From Curriculum Variation to Clinical Capability: Advancing Dermatology Education in Australia.

The Australasian journal of dermatology·2026
Same journal

Fatal Phenobarbital-Associated Toxic Epidermal Necrolysis With Severe Acute Kidney Injury and Multiorgan Failure: Prognostic Value of SCORTEN and ALDEN.

The Australasian journal of dermatology·2026
Same journal

Granulomatous Vasculitis: An Unusual Manifestation of Metastatic Crohn's Disease.

The Australasian journal of dermatology·2026
Same journal

The Rintala Advanced Modification (RAM) Flap: A Novel Technique for Off-Centre Nasal Reconstruction.

The Australasian journal of dermatology·2026
See all related articles

Area of Science:

  • Immunology
  • Dermatology
  • Pharmacology

Background:

  • Topical imiquimod stimulates interferon-alpha production, similar to intralesional interferon treatments.
  • Genital warts (condylomata acuminata) are a common condition often treated with various therapies.

Purpose of the Study:

  • To evaluate the efficacy and safety of topical imiquimod cream for treating external anogenital warts.
  • To determine the optimal dosing regimen for topical imiquimod in this patient population.

Main Methods:

  • A large double-blind trial randomized 311 patients with external anogenital warts.
  • Patients received either imiquimod 5% cream, imiquimod 1% cream, or a vehicle cream, applied overnight three times weekly for up to 16 weeks.

Main Results:

Related Experiment Videos

  • 50% of patients using 5% imiquimod cream achieved complete clearing of warts, compared to 21% for 1% imiquimod and 11% for vehicle (P < 0.0001).
  • Excluding non-therapy related discontinuations, 56% of patients on 5% imiquimod experienced complete wart clearance.
  • The recurrence rate for warts cleared with 5% imiquimod was 13%.

Conclusions:

  • Topical imiquimod 5% cream, applied overnight three times weekly, is an effective and well-tolerated treatment for external anogenital warts.
  • The observed low recurrence rate suggests potential for long-term efficacy, warranting further comparative studies.